Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 7 · 100%Moderate 0 · 0%High 0 · 0%

Drospirenone plus ethinylestradiol vs placebo

Mean daily rating of problem severity (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))

1 finding from 1 review

Oral contraceptives containing drospirenone for premenstrual syndrome 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 513 participants
Low

Drospirenone plus ethinylestradiol vs placebo

Mean change in daily rating of functional impairment: reduction of productivity (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))

1 finding from 1 review

Oral contraceptives containing drospirenone for premenstrual syndrome 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 432 participants
Low

Drospirenone plus ethinylestradiol vs placebo

Mean change in daily rating of functional impairment: social activities (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))

1 finding from 1 review

Oral contraceptives containing drospirenone for premenstrual syndrome 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 432 participants
Low

Drospirenone plus ethinylestradiol vs placebo

Mean change in daily rating of functional impairment: relationship interference (lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))

1 finding from 1 review

Oral contraceptives containing drospirenone for premenstrual syndrome 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 432 participants
Low

Drospirenone plus ethinylestradiol vs placebo

Changes in Premenstrual Tension Scale scores (observer‐rated; lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))

1 finding from 1 review

Oral contraceptives containing drospirenone for premenstrual syndrome 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 387 participants
Low

Drospirenone plus ethinylestradiol vs placebo

Changes in Premenstrual Tension Scale scores (self‐rated; lower score is better) · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))

1 finding from 1 review

Oral contraceptives containing drospirenone for premenstrual syndrome 2023 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 438 participants
Low

Drospirenone plus ethinylestradiol vs placebo

Withdrawals due to adverse events · women with premenstrual syndrome (most met DSM‐V criteria for premenstrual dysphoric disorder (PMDD))

Drospirenone plus ethinylestradiol may leads to higher withdrawal due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Oral contraceptives containing drospirenone for premenstrual syndrome 2023 · Cochrane Headline outcomes only
OR 3.41 [2.01, 5.78]
4 studies · 776 participants
Low